Table 3 The Estimation of the OOP Costs for Trastuzumab Treatment in 2016, 2018, and 2020
Time | 2018 | Â | ||||
|---|---|---|---|---|---|---|
Region | Urban | Rural (URRBMI) | Urban | Rural (URRBMI) | ||
UEBMI | URRBMI | UEBMI | URRBMI | |||
Price per dose (USD) | 1129 | 817 | ||||
Number of doses | 13 | 13 | ||||
Reimbursement rate | 80% | 65% | 65% | 80% | 65% | 65% |
OOP cost on Trastuzumab (USD) | 2935.4 | 5137.0 | 5137.0 | 2124.2 | 3717.4 | 3717.4 |
Annual disposable income per capita (USD) | 8534.5 | 5093.5 | 9528.1 | 5914.0 | ||
Ratio of OOP cost/annual disposable income per capita (%) | 34.4% | 60.2% | 100.9% | 22.3% | 39.0% | 62.9% |